VAXXILON Trademark

Trademark Overview


On Friday, December 16, 2022, a trademark application was filed for VAXXILON with the United States Patent and Trademark Office. The USPTO has given the VAXXILON trademark a serial number of 97720623. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Tuesday, March 11, 2025. This trademark is owned by Idorsia Pharmaceuticals Ltd.. The VAXXILON trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and veterinary products, namely, vaccines, and pharmaceutical and veterinary preparations for the prevention and treatment of infections; sanitary preparations for medical purposes; disinfectants
vaxxilon

General Information


Serial Number97720623
Word MarkVAXXILON
Filing DateFriday, December 16, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateTuesday, March 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 16, 2024

Trademark Statements


Goods and ServicesPharmaceutical and veterinary products, namely, vaccines, and pharmaceutical and veterinary preparations for the prevention and treatment of infections; sanitary preparations for medical purposes; disinfectants

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 12, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIdorsia Pharmaceuticals Ltd.
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressAllschwil 4123
CH

Party NameIdorsia Pharmaceuticals Ltd.
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressAllschwil 4123
CH

Trademark Events


Event DateEvent Description
Thursday, January 12, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 20, 2022NEW APPLICATION ENTERED
Tuesday, September 19, 2023ASSIGNED TO EXAMINER
Friday, September 29, 2023NON-FINAL ACTION WRITTEN
Friday, September 29, 2023NON-FINAL ACTION E-MAILED
Friday, September 29, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 12, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, December 12, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, December 12, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, December 12, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, December 12, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 27, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 16, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 16, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 12, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 3, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, September 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 3, 2024SOU EXTENSION 1 GRANTED
Tuesday, March 11, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, March 11, 2025SOU EXTENSION 2 FILED
Wednesday, March 12, 2025SOU EXTENSION 2 GRANTED
Wednesday, March 12, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 3, 2024SOU EXTENSION 1 FILED